341 related articles for article (PubMed ID: 21660135)
1. Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model.
Hayashi T
J Biomed Biotechnol; 2011; 2011():407031. PubMed ID: 21660135
[TBL] [Abstract][Full Text] [Related]
2. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren's syndrome.
Ohyama Y; Carroll VA; Deshmukh U; Gaskin F; Brown MG; Fu SM
J Immunol; 2006 Nov; 177(10):7391-7. PubMed ID: 17082658
[TBL] [Abstract][Full Text] [Related]
3. Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Yin H; Cabrera-Perez J; Lai Z; Michael D; Weller M; Swaim WD; Liu X; Catalán MA; Rocha EM; Ismail N; Afione S; Rana NA; Di Pasquale G; Alevizos I; Ambudkar I; Illei GG; Chiorini JA
Arthritis Rheum; 2013 Dec; 65(12):3228-38. PubMed ID: 23982860
[TBL] [Abstract][Full Text] [Related]
4. Submandibular and lacrimal gland immunoglobulin in the C3H.MRL-Faslpr autoimmune mouse model of Sjögren's syndrome.
Trune DR; Leedy DA
Laryngoscope; 1998 Nov; 108(11 Pt 1):1729-32. PubMed ID: 9818834
[TBL] [Abstract][Full Text] [Related]
5. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome.
Pijpe J; Kalk WW; Vissink A
J Rheumatol; 2003 Jan; 30(1):206-7; author reply 207. PubMed ID: 12508418
[No Abstract] [Full Text] [Related]
7. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
8. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome.
Fox PC; Speight PM
Crit Rev Oral Biol Med; 1996; 7(2):144-58. PubMed ID: 8875029
[TBL] [Abstract][Full Text] [Related]
9. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
Hayashi T; Shimoyama N; Mizuno T
Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
[TBL] [Abstract][Full Text] [Related]
10. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Lieberman SM; Kreiger PA; Koretzky GA
Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
[TBL] [Abstract][Full Text] [Related]
11. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis and diagnosis of Sjögren's syndrome].
Witte T
Z Rheumatol; 2010 Feb; 69(1):50-6. PubMed ID: 20012975
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.
Vosters JL; Landek-Salgado MA; Yin H; Swaim WD; Kimura H; Tak PP; Caturegli P; Chiorini JA
Arthritis Rheum; 2009 Dec; 60(12):3633-41. PubMed ID: 19950301
[TBL] [Abstract][Full Text] [Related]
15. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
17. Type I interferon receptor deficiency prevents murine Sjogren's syndrome.
Szczerba BM; Rybakowska PD; Dey P; Payerhin KM; Peck AB; Bagavant H; Deshmukh US
J Dent Res; 2013 May; 92(5):444-9. PubMed ID: 23533183
[TBL] [Abstract][Full Text] [Related]
18. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
19. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome.
Delaleu N; Jonsson R; Koller MM
Eur J Oral Sci; 2005 Apr; 113(2):101-13. PubMed ID: 15819815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
